<DOC>
	<DOCNO>NCT02292628</DOCNO>
	<brief_summary>This clinical trial phase I/II , double blind , randomize compare two group patient evaluate safety efficacy autologous mesenchymal stem cell adipose tissue ( CMMAd ) treatment faecal incontinence .</brief_summary>
	<brief_title>Study , Double Blind , Randomized , Comparing Two Groups Evaluate Safety Efficacy Autologous Mesenchymal Stem Cells From Adipose Tissue ( CMMAd ) Treatment Faecal Incontinence</brief_title>
	<detailed_description>In phase recruitment , 20 month duration , include 16 participant randomize one group intervention ( 8 patient group CMMAd / 8 patient group placebo ) . The phase follow-up every patient 12 month , though , provide patient see regularly study site study , conclude follow-up continued able obtain safety information efficacy 24 month .</detailed_description>
	<mesh_term>Fecal Incontinence</mesh_term>
	<criteria>1 . Males females age group 1880 yr . 2 . A unique internal sphincter defect / external ( 100 ยบ ) , level anal canal , cause ( except describe exclusion criterion ) . 3 . Severity faecal incontinence 12 Wexner Score / least six episode faecal incontinence period 28 day . 4 . Duration faecal incontinence least two year prior inclusion . 5 . Patients able understand requirement study , willing provide voluntary write informed consent . 1 . More external sphincter defect / level internal anal canal . 2 . Have receive treatment faecal failure bulk agent , neuromodulation surgery . 3 . Current anorectal tumor . 4 . Current anal fissure . 5 . Anorectal stenosis 6 . Chronic pelvic anorectal pain . 7 . Pregnant 6 month postpartum . 8 . Medical history infection Human Immunodeficiency Virus ( HIV ) severe immunocompromised state therapy immunosuppressive . 9 . Malignancies remission less year study . An exception basocellular carcinoma ( BCC ) `` remission '' less year . 10 . Bleeding diathesis current anticoagulant therapy . 11 . Chemotherapy 6 month precede study . 12 . Previous radiation evidence radiation injury treat area . 13 . Participation clinical study 3 month precede prestudy visit . 14 . Patients serious disorder . 15 . Patients uncontrolled inflammatory disease take drug prohibit protocol active perianal disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>